WHAT SCIENTISTS SAY ABOUT DPA OMEGA-3
Scholars at Harvard Medical School and Boston Children’s Hospital have suggested that maternal dietary intake of Omega-3 fatty acids correlates positively with regional brain volumes in 1-month-old term infants.Omega-3 fatty acids remained significantly correlated with infant brain volumes after subsetting to the 54 infants who were exclusively breastfed, but retinol and vitamin B12 did not.
Recent results showed that n-3 DPA is implied in the improvement of cardiovascular and metabolic disease risk markers, especially plasma lipid parameters, platelet aggregation, and cellular plasticity. Moreover, n-3 DPA is the most abundant n-3 LCPUFA in the brain after DHA and it could be specifically beneficial for elderly neuroprotection, and early-life development.
Almost 95% of NCAA Division I athletes fail to achieve the recommendation to consume 500 mg DHA+EPA per day. Love sports? Take your Omega-3 for brain and heart health!
A drug based on Eicosapentaenoic acid free fatty acid (EPA-FFA, or EPA in free fatty acid form) is soon entering clinical trials as a promising candidate to treat patients with symptoms of the novel coronavirus infection.
Following seal oil therapy, joint pain index, disease activity, and serum cholesterol level were significantly decreased, whereas the n-3 to n-6 ratio both in intestinal biopsies and blood was significantly increased.